Format

Send to

Choose Destination
Am J Gastroenterol. 2014 Jun;109(6):925-7. doi: 10.1038/ajg.2014.89.

PACSIN2 does not influence thiopurine-related toxicity in patients with inflammatory bowel disease.

Author information

1
1] Department of Surgical Sciences (Dunedin), VU University Medical Center, Amsterdam, The Netherlands [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.
2
Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam, The Netherlands.
3
1] QIMR Berghofer Medical Research Institute, Royal Brisbane Hospital, Brisbane, Queensland, Australia [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.
4
1] Centre for Inflammatory Bowel Disease, Fremantle Hospital, Fremantle, Western Australia, Australia [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.
5
1] Flinders Medical Centre, Flinders University of South Australia, Bedford Park, South Australia, Australia [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.
6
1] Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Adelaide, South Australia, Australia [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.
7
1] Department of Gastroenterology, Christchurch Hospital, Christchurch, New Zealand [2] On behalf of the Australian and New Zealand Inflammatory Bowel Disease Consortium.

Erratum in

  • Am J Gastroenterol. 2015 Jan;110(1):204. Studd, Corrie [added]; Bell, Sally J [added].
PMID:
24896764
DOI:
10.1038/ajg.2014.89
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center